# LympClear: Deep Learning for Venous Signal Suppression in MR Lymphangiography

> Improving Diagnostic Precision for Lower Limb Lymphedema: Suppressing Vein Signal Interference Using Deep Learning in MR Lymphangiography

[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.xxxxxx.svg)](https://doi.org/10.xxxx/zenodo.xxxxxx) <!-- å¯é€‰ï¼šåŒæ­¥å‘å¸ƒæ•°æ®æˆ–ä»£ç æ—¶ -->

---

![LympClear Workflow](å¹»ç¯ç‰‡9.JPG)

## ðŸ§  Overview

**LympClear** is a deep learningâ€“based framework developed to suppress venous signal interference in Magnetic Resonance Lymphangiography (MRL), significantly enhancing diagnostic accuracy for **lower extremity lymphedema (LE)**. This project introduces a novel signal suppression approach, dynamic image generation pipeline, and a lymphatic development grading system to improve anatomical clarity and support clinical decision-making.

---

## ðŸ” Background

MRL is widely used for LE diagnosis, but high-intensity venous signals often obscure lymphatic structures. LympClear solves this with a **brightness-matching enhanced nnUNet model**, enabling accurate vein suppression, improved visualization, and faster, more reliable interpretation.

---

## ðŸš€ Highlights

- ðŸ§  **Model**: Custom-trained nnUNet with brightness-matching strategy  
- ðŸ§ª **Dataset**: 1022 patients, 6162 dynamic scans, multi-center, 2007â€“2024  
- ðŸŽž **Output**: Cleaned MRL, dynamic flow GIFs, structural grading  
- ðŸ“ˆ **Clinical Impact**: Faster reading, higher diagnostic consistency, more confident planning  

---

## ðŸŽž Dynamic Visualization Examples

> Below are dynamic MRL sequences generated with LympClear. Vein suppression enhances contrast flow clarity and supports temporal interpretation.

### Example 1
![GIF 1](test1041.gif)

### Example 2
![GIF 2](test1046.gif)

### Example 3
![GIF 3](test1060.gif)


---

## ðŸ“Š Quantitative Results

| Metric                          | Before LympClear | After LympClear |
|---------------------------------|------------------|-----------------|
| Dice for vein segmentation      | N/A              | **0.940**       |
| Image quality (1â€“10)            | 6.7 Â± 1.1        | **7.5 Â± 0.9**   |
| Vein removal clarity            | 5.8 Â± 1.2        | **8.8 Â± 0.7**   |
| Lymphatic visibility            | 6.0 Â± 1.3        | **8.3 Â± 1.0**   |
| Radiologist reading time        | Baseline         | **â†“ 87%**       |
| Reflux detection improvement    | -                | **â†‘ 18.7%**     |
| Missed diagnosis rate           | 15.4%            | **7.2%**        |
| Cohenâ€™s Kappa (diagnostic Îº)    | 0.65             | **0.91**        |

---

## ðŸ§¬ Methodology

<p align="center">
  <img src="figures/model_architecture.png" width="600"/>
</p>

1. **Input**: 3D dynamic MRL scans  
2. **Preprocessing**: Normalization, registration, manual vein annotation  
3. **Training**: nnUNet with brightness matching  
4. **Output**:  
   - Vein-free MRL images  
   - Dynamic contrast agent flow GIFs   
   - Lymphatic development grading  

---

## ðŸ§ª Lymphatic Development Grading System

> **Table x. Lymphatic Development Grading System**

| Grade       | Development Status     | Imaging Characteristics |
|-------------|------------------------|--------------------------|
| **Grade I** | Aplasia                | Extremely sparse or nearly invisible lymphatic signals; maximum vessel diameter is very small (<2 mm), branching density approaches zero, with almost no abnormal collateral circulation. |
| **Grade II**| Hypoplasia             | Continuous lymph vessels <5, maximum diameter between 2â€“3 mm, slightly reduced branching density, only very few abnormal collateral vessels. Relatively low dilation rate (<10%). |
| **Grade III**| Hyperplasia           | Continuous lymph vessels >7, increased diameter (e.g., â‰¥4 mm), with alternating segments of significant dilation or narrowing; increased branching density and presence of multiple abnormal collateral vessels; moderate or higher dilation rate (â‰¥30%). |
| **Grade IV**| Severe Hyperplasia     | Highly dilated or clustered tortuous vessels, maximum diameter possibly >6 mm or larger; extremely high branching density, abundant abnormal collateral circulation; very high dilation rate (e.g., â‰¥50%), often accompanied by severe clinical symptoms. |


### Grade I: Aplasia
![Grade I](zeromip_image_comparison_vein_10716_0000.nii.png)  
*Extremely sparse lymphatic signals, <2 mm in diameter, minimal branching.*

### Grade II: Hypoplasia
![Grade II](zeromip_image_comparison_vein_10394_0000.nii.png)  
*Sparse vessels, slight dilation (2â€“3 mm), few abnormal collaterals.*

### Grade III: Hyperplasia
![Grade III](zeromip_image_comparison_vein_10043_0000.nii.png)  
*Thickened and tortuous vessels (â‰¥4 mm), moderate collaterals.*

### Grade IV: Severe Hyperplasia
![Grade IV](zeromip_image_comparison_vein_10897_0000.nii.png)  
*Severely dilated and clustered lymphatic network, extensive collateral flow.*


---

## ðŸ“¦ Repository Structure

```bash
LympClear/
â”œâ”€â”€ README.md                  # é¡¹ç›®ä»‹ç»ï¼ˆæœ¬æ–‡ä»¶ï¼‰
â”œâ”€â”€ figures/                   # æ¨¡åž‹ç»“æž„å›¾ã€æµç¨‹å›¾ã€åˆ†çº§å›¾
â”œâ”€â”€ gifs/                      # åŠ¨å›¾å±•ç¤º
â”œâ”€â”€ src/                       # æ¨¡åž‹ä»£ç ã€è®­ç»ƒå’ŒæŽ¨ç†è„šæœ¬
â”œâ”€â”€ model/                     # è®­ç»ƒå¥½çš„æ¨¡åž‹æƒé‡
â”œâ”€â”€ dataset/                   # æ•°æ®è¯´æ˜Žæˆ–æ ·ä¾‹
â”œâ”€â”€ notebooks/                 # åˆ†æžè„šæœ¬æˆ–æ¼”ç¤ºä»£ç 
â”œâ”€â”€ requirements.txt           # çŽ¯å¢ƒä¾èµ–
â””â”€â”€ LICENSE
